Pfizer Trading Polska Sp. z o.o. secures contract for Pharmaceutical Products - Delivery of a medicinal product containing the active substance inotuzumabum ozogamicini financed as part of the B65 drug program

Poland, Feb. 18 -- Poland based Pfizer Trading Polska Sp. z o.o. has secured contract from Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie for Pharmaceutical Products - Delivery of a medicinal product containing the active substance inotuzumabum ozogamicini financed as part of the B65 drug program. The value of the contract is worth 70486006 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....